Matthews China Small Companies Fund
Period ended 30 September 2018
For the quarter ending 30 September 2018, the Matthews China Small Companies Fund returned -15.41%, underperforming its benchmark, the MSCI China Small Cap Index, which returned -10.16% over the same period.
Trade war tensions and geopolitical risks dominated headlines during the third quarter. Additional uncertainty over the near-term outlook for the market was brought on by Chinese domestic policies toward deleveraging and regulating the consumer services economy. These factors all negatively impacted Chinese equity markets in terms of both performance and volatility. For the first time in a while, we saw a noticeable slowdown in domestic retail consumption of large-ticket items, such as autos and home decorations, driven by domestic deleveraging. Even though retail sales and industrial production figures continued to meet expectations through August, investors worried about a downward trajectory in the near term—thus ignoring the strong August data. China's central bank, the People's Bank of China, appeared to be cognizant of the near-term policy and geopolitical headwinds and therefore continued to be accommodative by lowering interest rates twice during the quarter. The government's determination in steering China's longer term structural reform, however, remains solid as it maintained its strict controls over the riskier parts of the nation's lending system.
From both a top-down and bottom-up perspective, we continue to anticipate long-term sustainable growth in the Chinese economy and in corporate earnings. The market's concerns over the rising cost of funding and escalating trade tensions should, in our view, have little impact on China's smaller companies given their domestic focus and lower dependence on financial leverage. However, China's recent policies toward the consumer services economy does have near-term negative impacts on sentiment for smaller companies.
Performance Contributors and Detractors:
For the third quarter, our poor stock selection in the information technology and consumer discretionary sectors contributed most to the Fund's underperformance versus the benchmark. The consumer staples sector provided positive support to Fund performance.
Silergy, China's analog semiconductor company, and TK Group, China's largest precision molding company, were among the top individual detractors to Fund performance in the third quarter. Over the long run we firmly believe Silergy will continue to benefit from China's plans to become self-sufficient in semiconductor production. However, during the third quarter, Silergy was hit with a wall of worry as the global semiconductor industry was sold off on cyclical concerns. We believe these concerns are misplaced for Silergy because analog semiconductors are much less cyclical and the trade war actually accelerates China's need for self-sufficiency in the production of semiconductors. TK Group was also sold off as investors worried about trade tariffs that could impact its plastic molds and parts. We see some risk for short-term front loading of inventory by TK's customers. Longer term, TK's global competitiveness remains strong despite the threat of tariffs. We focus on companies with pricing power as a result of a sustainable moat. TK's pricing power within the plastics mold industry is high, such that we believe it will be able to pass on incremental costs related to tariffs.
Among the top contributors to Fund performance during the third quarter were Huaxin Cement and Yihai International Holding. Huaxin Cement continued to benefit from China's overall supply-side reform to clean up the environment. Yihai International Holding manufactures and sells a leading hot pot soup base and condiment brand for both restaurants and retail consumers. We believe the company has strong growth visibility given the popularity of its associated hot pot restaurant chain and its rapidly growing new business in restaurant supplies.
Notable Portfolio Changes:
During the third quarter, Huaxin Cement “graduated” from our portfolio—meaning it did well enough while we held it in our portfolio that it saw its market capitalization exceed our typical small-cap range. We also exited China Zhengtong Auto Services due to its relatively high leverage levels and the continued unfavorable funding environment toward this sector. We continue to selectively add innovative companies to our portfolio, especially in the technology and consumer-related sectors. China's small-cap universe continues to be a fertile hunting ground for finding cash flow-rich growth stocks at reasonable valuations, and we have been able to easily replace our “graduates” with attractive new holdings.
During the quarter, we initiated a position in Microport Scientific, a leading medical device company in China. We believe the company has strong growth visibility given its product cycle in orthopedics, stents and pacemakers. We believe the company has passed the toughest parts of its business integration process and will be able to deliver much better profitability ahead.
We remain cautiously optimistic about China's small-cap market despite heightened market volatility as we focus rigorously on the sound fundamentals of our portfolio companies. From a macroeconomic perspective, we continue to believe China has the ability to stabilize its economy through fiscal spending, interest rate adjustments and currency management. In addition, steps taken to correct China's structural issues are continuing on the right track, despite the near-term pains of a deleveraging economy. We are focused on seeking innovative and capital-efficient small companies that are relatively insulated from macroeconomic uncertainties. We will continue to seek companies with sustainable, quality earnings streams, strong cash flows and good balance sheets that can weather uncertain economic conditions. We believe sectors such as industrial automation, health care and technology are among the most attractive from a secular growth perspective.
Investing in small- and mid-size companies is
more risky than investing in large companies as they may be more volatile and
less liquid than larger companies.
Performance figures discussed in any of the Fund Manager Commentaries reflect that of the Institutional Accumulation Class Shares and have been calculated in USD, including ongoing charges and excluding subscription fee and redemption fee investors might have to pay. Performance details provided for the Fund are based on a NAV-to-NAV basis, with any dividends reinvested, and are net of management fees and other expenses. Past performance information is not indicative of future performance. Investors may not get back the full amount invested.
The information contained herein has been derived from sources believed to be reliable and accurate at the time of compilation, but no representation or warranty (express or implied) is made as to the accuracy or completeness of any of this information. Matthews International Capital Management, LLC (“Matthews Asia”) and its affiliates do not accept any liability for losses either direct or consequential caused by the use of this information.
Information contained herein is sourced from Matthews Asia unless otherwise stated. The views and opinions in this commentary were as of the report date, subject to change and may not reflect the writer’s current views. They are not guarantees of performance or investment results and should not be taken as investment advice. Investment decisions reflect a variety of factors, and the managers reserve the right to change their views about individual stocks, sectors, and the markets at any time. As a result, the views expressed should not be relied upon as a forecast of the Fund’s future investment intent. It should not be assumed that any investment will be profitable or will equal the performance of any securities or any sectors mentioned herein. The information does not constitute a recommendation to buy or sell any securities mentioned.
Investors should not invest in the Fund solely based on the information in this material alone. Please refer to the Hong Kong Offering Document for further details of the risk factors.
Sources: Brown Brothers Harriman (Luxembourg) S.C.A, Matthews Asia, FactSet Research Systems, Bloomberg